In studies on pancreatic cancer, it was observed that silencing LINC01410 expression resulted in a decrease in IFITM3 protein levels in BxPC-3 cells, along with a downregulation of cell proliferation-associated proteins, including CDK6, Cyclin D2, and proliferating cell nuclear antigen (PCNA). This evidence concerns the gene PCNA and pancreatic neoplasm.